Home india India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.53 for quarter ended Sep 2021

India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.53 for quarter ended Sep 2021

0
India Equity: Concord_Drugs (#538965) declares Quarterly Results. EPS = Rs 0.53 for quarter ended Sep 2021

Join the India Equity Telegram Group for analysis, updates and results

538965 has declared results for the period ended Sep 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Sep 2021 is Rs 9.83 cr compared to Rs 16.57 cr for period ended Sep 2020, a fall of 40.7%
  • Operating Profits reported at Rs 1.64 cr for period ended Sep 2021 vis-vis 0.89 for period ended Sep 2020 .
  • Operating Margins expanded 1131.2 bps for period ended Sep 2021 vis-vis Sep 2020 .
  • The EPS for Sep 2021 was Rs 0.53 compared to Rs 0.79 for previous quarter ended Jun 2021 and Rs 0.09 for Sep 2020
  • The stock is trading at Rs 34.80 and a market cap of Rs 30 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: 538965

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter